New product: Leqvio (inclisiran) 284 mg solution for injection in pre filled syringe

Inclisiran is licensed for the treatment of adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet, either alone or in combination with a statin or statin with other lipid-lowering therapies.

Source:

electronic Medicines compendium